• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭初始诊断时合并症的谱:一项病例对照研究。

The spectrum of comorbidities at the initial diagnosis of heart failure a case control study.

机构信息

Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany.

Internal Medicine I, Central Hospital Bremerhaven, Bremerhaven, Germany.

出版信息

Sci Rep. 2022 Feb 17;12(1):2670. doi: 10.1038/s41598-022-06618-5.

DOI:10.1038/s41598-022-06618-5
PMID:35177698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8854549/
Abstract

The prognosis of heart failure (HF) patients is determined to a decisive extent by comorbidities. The present study investigates the association between a broad spectrum of diseases and the occurrence of HF in a large collective of outpatients. This retrospective case control study assessed the prevalence of 37 cardiac and extracardiac diseases in patients with an initial diagnosis of heart failure (ICD-10: I50) in 1,274 general practices in Germany between January 2005 and December 2019. The study is based on the Disease Analyzer database (IQVIA), which contains drug prescriptions, diagnoses, and basic medical and demographic data. Patients with and without heart failure were matched by sex, age, and index year. Hazard regression models were conducted to evaluate the association between different disease entities and heart failure. The present study included 162,246 patients with heart failure and 162,246 patients without heart failure. Mean age [SD] was 73.7 [12.1] years; 52.6% were women. Out of 37 predefined diagnoses, 36 were more prevalent in HF patients. The highest prevalence was primary hypertension (63.4% in HF patients vs. 53.3% in controls, p < 0.001) followed by lipid metabolism disorders (34.6% in HF patients vs. 29.1% in HF patients p < 0.001) and diabetes mellitus type II (32.2% in HF patients vs. 25.2% in controls, p < 0.001). In the regression analysis, 19 diseases were significantly associated with heart failure. Non-cardiovascular diagnoses strongly associated with HF were obesity (HR = 1.46), chronic bronchitis and COPD (HR = 1.41), gout (HR: 1.41), and chronic kidney disease (HR = 1.27). In the present study, we identified a variety of cardiac and extracardiac diseases associated with heart failure. Our data underscore the immense importance of comorbidities, even as early as at the stage of initial diagnosis of heart failure.

摘要

心力衰竭(HF)患者的预后在很大程度上取决于合并症。本研究调查了广泛的疾病与大量门诊患者 HF 发生之间的关联。本回顾性病例对照研究评估了 2005 年 1 月至 2019 年 12 月期间德国 1274 家普通诊所中初始诊断为心力衰竭(ICD-10:I50)的患者中 37 种心脏和心脏外疾病的患病率。该研究基于包含药物处方、诊断以及基本医疗和人口统计数据的疾病分析器数据库(IQVIA)。心力衰竭患者和无心力衰竭患者按性别、年龄和索引年进行匹配。使用风险回归模型评估不同疾病实体与心力衰竭之间的关联。本研究包括 162246 例心力衰竭患者和 162246 例无心力衰竭患者。平均年龄[标准差]为 73.7[12.1]岁;52.6%为女性。在 37 种预先定义的诊断中,有 36 种在心力衰竭患者中更为常见。患病率最高的是原发性高血压(心力衰竭患者中为 63.4%,对照组中为 53.3%,p<0.001),其次是脂质代谢紊乱(心力衰竭患者中为 34.6%,对照组中为 29.1%,p<0.001)和 II 型糖尿病(心力衰竭患者中为 32.2%,对照组中为 25.2%,p<0.001)。在回归分析中,有 19 种疾病与心力衰竭显著相关。与心力衰竭强烈相关的非心血管诊断包括肥胖症(HR=1.46)、慢性支气管炎和 COPD(HR=1.41)、痛风(HR:1.41)和慢性肾脏病(HR=1.27)。在本研究中,我们确定了多种与心力衰竭相关的心脏和心脏外疾病。我们的数据强调了合并症的重要性,即使在心力衰竭的初始诊断阶段也是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd9/8854549/0a6eea4d65e7/41598_2022_6618_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd9/8854549/29ccdd4a5594/41598_2022_6618_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd9/8854549/0a6eea4d65e7/41598_2022_6618_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd9/8854549/29ccdd4a5594/41598_2022_6618_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cd9/8854549/0a6eea4d65e7/41598_2022_6618_Fig2_HTML.jpg

相似文献

1
The spectrum of comorbidities at the initial diagnosis of heart failure a case control study.心力衰竭初始诊断时合并症的谱:一项病例对照研究。
Sci Rep. 2022 Feb 17;12(1):2670. doi: 10.1038/s41598-022-06618-5.
2
Preheart failure comorbidities and impact on prognosis in heart failure patients: a nationwide study.心力衰竭前合并症及其对心力衰竭患者预后的影响:一项全国性研究。
J Intern Med. 2020 Jun;287(6):698-710. doi: 10.1111/joim.13033. Epub 2020 Feb 26.
3
Heart failure is associated with an increased incidence of cancer diagnoses.心力衰竭与癌症诊断发病率的增加有关。
ESC Heart Fail. 2021 Oct;8(5):3628-3633. doi: 10.1002/ehf2.13421. Epub 2021 Jun 27.
4
Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: Insights from the Colombian heart failure registry (RECOLFACA).拉丁美洲某国慢性心力衰竭患者的共病情况及预后:来自哥伦比亚心力衰竭登记处(RECOLFACA)的见解
Int J Cardiol. 2023 May 1;378:123-129. doi: 10.1016/j.ijcard.2023.02.020. Epub 2023 Feb 13.
5
Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.植入式心脏复律除颤器用于一级预防的心力衰竭患者合并症与预后的关系
J Am Heart Assoc. 2015 Aug 6;4(8):e002061. doi: 10.1161/JAHA.115.002061.
6
Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients.非酒精性脂肪性肝病 (NAFLD) 与新发心力衰竭风险:对 173966 例患者的回顾性分析。
Clin Res Cardiol. 2023 Oct;112(10):1446-1453. doi: 10.1007/s00392-023-02250-z. Epub 2023 Jul 6.
7
Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry.射血分数降低型与射血分数保留型心力衰竭患者的非心脏合并症与死亡率:一项使用瑞典心力衰竭注册研究的分析。
Clin Res Cardiol. 2019 Sep;108(9):1025-1033. doi: 10.1007/s00392-019-01430-0. Epub 2019 Feb 20.
8
Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study.2型糖尿病及心力衰竭对预后的影响与其他心血管疾病的比较:一项全国性研究
Circ Cardiovasc Qual Outcomes. 2020 Jul;13(7):e006260. doi: 10.1161/CIRCOUTCOMES.119.006260. Epub 2020 Jun 23.
9
Heart failure in primary care: prevalence related to age and comorbidity.基层医疗中的心力衰竭:患病率与年龄及合并症的关系
Prim Health Care Res Dev. 2019 Jul 29;20:e79. doi: 10.1017/S1463423618000889.
10
Increased comorbidities in heart failure patients ≥ 85 years but declined from >90 years: data from the Swedish Heart Failure Registry.心力衰竭患者≥85 岁的合并症增加,但>90 岁的合并症减少:来自瑞典心力衰竭登记处的数据。
Int J Cardiol. 2013 Sep 10;167(6):2747-52. doi: 10.1016/j.ijcard.2012.06.095. Epub 2012 Jul 16.

引用本文的文献

1
Health-related quality of life and associated factors among individuals with heart failure attending public hospitals in Nekemte town, Western Oromia, Ethiopia: a cross-sectional study.埃塞俄比亚奥罗米亚西部内克梅特镇公立医院心力衰竭患者的健康相关生活质量及其相关因素:一项横断面研究。
BMC Cardiovasc Disord. 2025 Jul 28;25(1):550. doi: 10.1186/s12872-025-05007-w.
2
The association of hemorrhoids with the incidence of heart failure: a nationwide cohort study.痔疮与心力衰竭发病率的关联:一项全国性队列研究。
Ann Transl Med. 2025 Apr 30;13(2):14. doi: 10.21037/atm-24-218. Epub 2025 Apr 29.
3
A Systematic Review of Codelists to Identify Chronic Bronchitis and Emphysema in Routine Electronic Healthcare Record Data and Derivation of a Standardized Codelist for Future Research.

本文引用的文献

1
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
2
The struggle towards a Universal Definition of Heart Failure-how to proceed?迈向心力衰竭通用定义的努力——如何推进?
Eur Heart J. 2021 Jun 21;42(24):2331-2343. doi: 10.1093/eurheartj/ehab082.
3
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.
一项关于在常规电子医疗记录数据中识别慢性支气管炎和肺气肿的代码集的系统评价以及用于未来研究的标准化代码集的推导。
Int J Chron Obstruct Pulmon Dis. 2025 May 23;20:1679-1691. doi: 10.2147/COPD.S501421. eCollection 2025.
4
Refining a hybrid music therapy intervention for chronic obstructive pulmonary disease and heart failure: a single arm pilot study.优化慢性阻塞性肺疾病和心力衰竭的混合音乐疗法干预:单臂试点研究。
BMC Complement Med Ther. 2025 Apr 14;25(1):139. doi: 10.1186/s12906-025-04887-x.
5
Disease Network-Based Approaches to Study Comorbidity in Heart Failure: Current State and Future Perspectives.基于疾病网络的心力衰竭共病研究方法:现状与未来展望
Curr Heart Fail Rep. 2024 Dec 27;22(1):6. doi: 10.1007/s11897-024-00693-7.
6
Impact of the COVID-19 pandemic on hospital-based heart failure care in New South Wales, Australia: a linked data cohort study.COVID-19 大流行对澳大利亚新南威尔士州基于医院的心力衰竭治疗的影响:一项关联数据队列研究。
BMC Health Serv Res. 2024 Nov 8;24(1):1364. doi: 10.1186/s12913-024-11840-0.
7
Race, Social Determinants of Health, and Comorbidity Patterns Among Participants with Heart Failure in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.中风地理和种族差异原因(REGARDS)研究中的心衰参与者的种族、健康的社会决定因素及共病模式
Discov Soc Sci Health. 2024;4(1). doi: 10.1007/s44155-024-00097-x. Epub 2024 Aug 6.
8
Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort-the DIABET-IC study.2型糖尿病患者心力衰竭的患病率和发病率:一项全国性前瞻性队列研究——DIABET-IC研究的结果
Cardiovasc Diabetol. 2024 Jul 16;23(1):253. doi: 10.1186/s12933-024-02358-0.
9
Effect of dapagliflozin on uric acid in patients with chronic heart failure and hyperuricemia.达格列净对慢性心力衰竭合并高尿酸血症患者尿酸的影响。
World J Clin Cases. 2024 Jun 26;12(18):3468-3475. doi: 10.12998/wjcc.v12.i18.3468.
10
Computational modeling of heart failure in microgravity transitions.微重力转变中心力衰竭的计算建模。
Front Physiol. 2024 Jun 21;15:1351985. doi: 10.3389/fphys.2024.1351985. eCollection 2024.
心力衰竭的通用定义和分类:美国心力衰竭学会、欧洲心脏病学会心力衰竭协会、日本心力衰竭学会和心力衰竭通用定义写作委员会的报告:得到加拿大心力衰竭学会、印度心力衰竭协会、澳大利亚和新西兰心脏病学会以及中国心力衰竭协会的认可。
Eur J Heart Fail. 2021 Mar;23(3):352-380. doi: 10.1002/ejhf.2115. Epub 2021 Mar 3.
4
Reappraising the role of inflammation in heart failure.重新评估炎症在心力衰竭中的作用。
Nat Rev Cardiol. 2020 May;17(5):269-285. doi: 10.1038/s41569-019-0315-x. Epub 2020 Jan 22.
5
Dementia and the heart failure patient.痴呆与心力衰竭患者
Eur Heart J Suppl. 2019 Dec;21(Suppl L):L28-L31. doi: 10.1093/eurheartj/suz242. Epub 2019 Dec 23.
6
Introduction to the special issue entitled 'Heart failure management of the elderly patient: focus on frailty, sarcopenia, cachexia, and dementia'.特刊《老年患者的心衰管理:关注衰弱、肌少症、恶病质和痴呆》引言
Eur Heart J Suppl. 2019 Dec;21(Suppl L):L1-L3. doi: 10.1093/eurheartj/suz234. Epub 2019 Dec 23.
7
Long-term risk of stroke and its predictors in transient ischaemic attack patients in Germany.德国短暂性脑缺血发作患者的长期卒中风险及其预测因素。
Eur J Neurol. 2020 Apr;27(4):723-728. doi: 10.1111/ene.14136. Epub 2019 Dec 26.
8
Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany.非酒精性脂肪性肝病对德国初级保健人群心血管疾病发病率的影响。
Dig Dis Sci. 2020 Jul;65(7):2112-2119. doi: 10.1007/s10620-019-05986-9. Epub 2019 Dec 3.
9
Prevention and Treatment of Alzheimer's Disease: Biological Mechanisms of Exercise.预防和治疗阿尔茨海默病:运动的生物学机制。
J Alzheimers Dis. 2019;69(2):311-338. doi: 10.3233/JAD-180958.
10
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.心脏肾脏综合征:分类、病理生理学、诊断和治疗策略:美国心脏协会的科学声明。
Circulation. 2019 Apr 16;139(16):e840-e878. doi: 10.1161/CIR.0000000000000664.